![]() ![]() Is SBTX a good stock to buy? Silverback Therapeutics, Inc. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards Silverback Therapeutics, Inc. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. The Rosen Law Firm, P.A.The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st. Prior results do not guarantee a similar outcome. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.įollow us for updates on LinkedIn:, on Twitter: or on Facebook. You may also remain an absent class member and do nothing at this point. Until a class is certified, you are not represented by counsel unless you retain one. toll-free at 86 or email or for information on the class action. To join the Silverback class action, go to or call Phillip Kim, Esq. When the true details entered the market, the lawsuit claims that investors suffered damages. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.ĭETAILS OF THE CASE: According to the lawsuit, the IPO documents featured and defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Silverback's lead product candidate SBT6050 (a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers) was less effective than the Company had represented to investors (2) accordingly, Silverback had overstated SBT6050's commercial and/or clinical prospects and (3) as a result, the IPO documents and defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. In 2019 alone the firm secured over $438 million for investors. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. ![]() Many of these firms do not actually litigate securities class actions. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. ![]() If you wish to serve as lead plaintiff, you must move the Court no later than January 4, 2022. A class action lawsuit has already been filed. WHAT TO DO NEXT: To join the Silverback class action, go to or call Phillip Kim, Esq. SO WHAT: If you purchased Silverback securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. (NASDAQ: SBTX): (1) pursuant and/or traceable to the registration statement and prospectus issued in connection with Silverback's Deceminitial public offering ("IPO") and/or (2) between Decemand September 10, 2021, inclusive (the "Class Period"), of the important Janulead plaintiff deadline. WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |